Skip to Main Content


Strategies and Considerations When Breaking Up Mass Actions After BMS

September 6, 2017 - DRI's The Voice
Social Logo Social Logo Social Logo

by Seth Wamelink and Madeline Dennis, published in DRI's The Voice

Numerous articles have detailed the Supreme Court’s groundbreaking decision in Bristol-Myers Squibb Co. v. Superior Ct., 137 S. Ct. 1773 (2017) (BMS). This article addresses the mechanics and practical considerations when deciding whether to use BMS to break up a mass action.

To read the article, click here.

Related Attorneys

Related Article

8th Annual Update of Take-Home Asbestos Duty Decisions: 2017 Rulings Highlight Litigation Landscape More
lingua negoti
The language of business.
Perspectives on employee benefits, executive compensation and ERISA litigation to help you attract and retain talent.
Ohio Environmental
Insights and commentary for the business and legal community.